Estudantes dos cursos de Medicina e de Farmácia da Unaerp apresentaram trabalhos no 50th Brazilian Congress of Pharmacology and Experimental Therapeutics – SBFTE/2018, que aconteceu entre os dias 25 e 28 de setembro, no Centro de Convenções de Ribeirão Preto.
Os projetos estão vinculados a Unidade de Biotecnologia e Programa de Iniciação Científica do curso de Medicina - Núcleo de Pesquisa e envolve graduandos que desenvolvem projetos de iniciação cientifica.
Seguem os projetos apresentados no evento:
PENTOXIFYLLINE EXERTS ANTIINFLAMMATORY EFFECTS, INHIBITS MMP-2 ACTIVITY AND ATTENUATES RENOVASCULAR HYPERTENSION-INDUCED CARDIAC HYPERTROPHY.
Thais R.Victorino1, Bonacio GF2, Dellalibera-Jovilliano,R1, Franca SC2, Prado CM3, Rizzi E2.1 Faculty of Medicine, University of Ribeirao Preto, Brazil. 2 Biotechnology Unit, University of Ribeirao Preto, Brazil. 3 Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of Sao Paulo, Ribeirao Preto, Brazil
RESVERATROL DECREASES MMP-2 ACTIVITY IN VITRO AND ATTENUATES RENOVASCULAR HYPERTENSION-INDUCED PVAT REMODELING.
Gisele B. Fumegalli1, Rosalin, MG2, Camassola GB2,Carmo, MFA2, Basso FG3, Restini, C.B.A1,4; Rizzi, E1.1 Biotechnology Unit, University of Ribeirao Preto, Brazil. 2 Faculty of Medicine, University of Ribeirao Preto, 3Faculty of Dentistry, University of Ribeirao Preto, Brazil. 4 Michigan State University, Dept Pharmacology & Toxicology, MI - USA
PENTOXIFYLLINE ATTENUATION OF VASCULAR HYPERTROPHY IS NOT ASSOCIATED WITH TNF-Α PATHWAY IN RENOVASCULAR HYPERTENSION.
Matheus P.Pereira1, Bonacio GF2, Garcia VT2, Alvez CAC2, Dellalibera-Jovilliano,R1, Franca SC2, Tanus-Santos JE3, Rizzi E2.1 Faculty of Medicine, University of Ribeirao Preto, Brazil. 2 Biotechnology Unit, University of Ribeirao Preto, Brazil. 3 Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
